Brief: Rocket Pharmaceuticals Announces Appointment Of Mikael Dolsten, M.D., Ph.D., To Board Of Directors
10/09/2024 12:45
Sept 10 (Reuters) - Rocket Pharmaceuticals Inc RCKT.O :
* ROCKET PHARMACEUTICALS ANNOUNCES APPOINTMENT OF MIKAEL
DOLSTEN,
M.D., PH.D., TO BOARD OF DIRECTORS
Source text for Eikon: ID:nBw65NBGla
Further company coverage: RCKT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rocket Pharmaceuticals
See all newsRocket Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Rocket Pharmaceuticals, Inc. expected to post a loss of 42 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Accendra Health, Celestica, Sionna Therapeutics
Rocket Pharmaceuticals posts Q2 profit helped by PRV sale
Brief: Rocket Pharmaceuticals Q2 EPS USD 1.08